Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2017-02-08 Report Publication Anno…
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Notice of Interim Results
Report Publication Announcement Classification · 99% confidence The document is very short (3039 characters) and explicitly states its purpose: 'Notice of Interim Results'. It announces that the company 'will be announcing its interim results for the half year ended 30 November 2016 on Friday 10 February 2017.' It also provides details for an analyst conference call related to these results. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing the publication or timing of a report, rather than being the report itself, should be classified as a Report Publication Announcement (RPA). The presence of the RNS Number further confirms it is a regulatory announcement about an upcoming event/report.
2017-02-08 English
Positive interim data from NHS Screening Trial
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement. The content discusses positive interim data from a clinical trial (NHS Lung Cancer Screening Trial) involving the company's product (EarlyCDT®-Lung) and announces that this information will be presented at a conference. This is a general update on company progress and scientific findings, not a formal financial report (like 10-K or IR), a specific management change (MANG), or a dividend announcement (DIV). Since it is a formal announcement released via the RNS system that doesn't fit the more specific categories like ER, CT, or DIRS, the most appropriate classification is the general Regulatory Filings category (RNS). The document length (6526 chars) is substantial enough that it is the primary content, not just a brief announcement of a report (which would suggest RPA).
2016-12-06 English
PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR
Remuneration Information Classification · 99% confidence The document is identified by the RNS Number (6216Q) and explicitly states it is a 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR' (Persons Discharging Managerial Responsibilities). It details the awarding of share options to an executive (Dan Calvo). This type of insider transaction disclosure falls directly under the definition of Director's Dealing (DIRS). Although it is an RNS announcement, the specific content is highly indicative of DIRS, which is a more specific classification than the general RNS fallback.
2016-11-30 English
Result of Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states it is announcing the 'Result of Annual General Meeting' and confirms that 'all resolutions were duly passed' at the AGM held earlier that day. This directly corresponds to the definition of AGM Information (AGM-R). Although it is a short announcement, the content is the result itself, not an announcement *about* the publication of a report, making AGM-R more specific than RPA or RNS. The RNS Number suggests it was filed via the Regulatory News Service, but the content is specific to the AGM result.
2016-11-30 English
Group of companies' accounts made up to 2016-05-31
Regulatory Filings
2016-11-30 English
Grant of options
Director's Dealing Classification · 100% confidence The document is explicitly labeled with an 'RNS Number' and contains a 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND PERSONS CLOSELY ASSOCIATED WITH THEM'. It details the awarding of share options to Directors and Persons Discharging Managerial Responsibilities (PDMRs). This type of filing, which reports personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2016-11-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.